DEA

The DEA published a new rule on Thursday that will allow researchers to apply to cultivate cannabis for research purposes.

Cannabis researcher Dr. Lyle Craker has filed suit over the DEA’s failure to license additional growers for research-grade cannabis.

The DEA is seeking a contractor capable of incinerating up to 8,000 pounds of cannabis and other federally prohibited substances per day.

MAPS, the Multidisciplinary Association of Psychedelic Studies, issued a public response to the DEA’s repeatedly delayed licensing of additional research-grade cannabis growers.

Federal investigators with the FBI and DEA have partnered with Maine State Police to investigate two companies operating in the cannabis space.

Lawmakers in the House of Representatives have advanced a highways infrastructure bill that includes language making products from state-legal cannabis markets available for federal research purposes.

The DEA has requested and received permission to investigate and police people taking part in the ongoing protests over the death of George Floyd.

The DEA has removed Epidiolex, the CBD-based epilepsy medication made by GW Pharmaceuticals, from the federal controlled substances list.

The DEA has unveiled a new rule proposal that would finally open up the licensing of new research-grade cannabis cultivators.

The DEA admitted in a recent report to Congress that state-wide cannabis legalization policies have overall reduced demand in the illicit cannabis market.

The USDA has removed a requirement for the coming growing season that all hemp crops be tested by DEA-approved labs.

Lawmakers questioned officials from the DEA, FDA, and National Institutes of Health yesterday about the federal limitations on cannabis research; Rep. Joe Kennedy III (D-MA) accused the government agencies of hiding behind a cannabis “Catch-22.”

The DEA has announced an expansion of medical cannabis research options and a change in policy: hemp cultivators no longer need to register with the agency in light of the crop’s federal legalization.

Dr. Sue Sisley of the Scottsdale Research Institute is suing the DEA over hurdles to cannabis research — specifically, that government-sourced cannabis is nothing like the products being used en masse throughout legal states.

A federal appeals court has ruled that a lawsuit challenging the prohibition of cannabis can remain open — despite being dismissed last year — so that actions can be taken against the Drug Enforcement Agency if it fails to address the issue of cannabis’ Schedule 1 status.

The DEA is carefully monitoring and sometimes modifying interviews by its personnel — and other representations of the agency — as part of a larger media effort to control how it appears in documentaries, reality shows, and dramas.

The U.S. Department of Agriculture has released guidance allowing farmers to import hemp seed from international industrial hemp markets — as long as said seeds are documented to produce plants containing less THC than the federal limit of 0.3 percent.

The DEA claims the houses raided were all connected to east coast crime syndicates, but the raids have resulted in no arrests.